PHIL DAVF: PHIL Embolic System in the Treatment of Dural Arteriovenous Fistulas.
This study enrolls people with brain artery/vein abnormalities. The purpose of this study is to collect information about how the a device called the PHIL® Embolic System works to treat this issue, called intracranial dural arteriovenous fistulas. The device contains a liquid that is meant to reduce blood flow to the area that needs treatment.
You will be involved in this study for about 6 months. Study takes place at Gates Vascular Institute, 875 Ellicott St, Buffalo NY 14203.
Compensation is not available.
To evaluate the safety and probable benefit of MicroVention, Inc. PHIL?? Liquid Embolic material for the treatment of intracranial dural arteriovenous fistulas.
Adults ages 22-80.
Have been diagnosed with a dural arteriovenous fistula (DAVF).
Let us know how the study team can reach you.
If you do not hear back within 2 business days, reach out to the study team directly at the contact information above or email firstname.lastname@example.org and someone will assist you.